How is the Controlled Release Drug Delivery Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the controlled release drug delivery market?
The market size of controlled release drug delivery has seen a swift expansion in the past years. The market worth is predicted to rise from $65.44 billion in 2024 to $73.01 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. This substantial growth experienced during the historical period is linked to the advent of innovative drug delivery systems, initial polymer-based formulations, the introduction of microencapsulation techniques, the rise of transdermal delivery, regulatory authorizations, and standardization.
What will be the controlled release drug delivery market size in the future?
In the coming years, the controlled release drug delivery market is projected to experience significant growth. It is anticipated to reach a value of $119.41 billion in 2029, with a CAGR of 13.1%. Factors that are likely to contribute to this growth during the forecast period include a shift towards personalized medicine, patient-friendly technology integration, growth of biologics and biosimilars, market expansion in emerging regions, and advances in polymer science. Key trends to watch out for in this period involve biodegradable and biocompatible materials, developments in nanotechnology, personalized and targeted treatments, enhancements in implantable devices, and creative encapsulation techniques.
Get your controlled release drug delivery market report here!
What main drivers are fueling expansion in the controlled release drug delivery market?
The growth of the controlled release drug delivery market is projected to be accelerated by the increasing occurrences of chronic diseases. These long-term illnesses, also known as noncommunicable diseases, such as heart disease, diabetes, and cancer, necessitate ongoing medical care and may restrict daily activities. Delivering drugs in a controlled-release manner is essential for managing these persistent diseases. Prolonged medication release formulations are vital for those living with chronic conditions that demand years of treatment or for those in locations with restricted healthcare resources and access. For instance, a report from the World Health Organization (WHO), a Switzerland-based health-specialized agency, in September 2022, revealed that chronic diseases account for 74 percent of worldwide deaths, totaling 41 million lives lost each year. 17 million of these deaths occur before the age of 70, and 77 percent of chronic disease deaths happen in low- to middle-income countries. Projections indicate that these statistics may increase in the future. As a result of these trends, the controlled release drug delivery market is experiencing significant growth driven by an escalating prevalence of chronic diseases.
What key areas define the segmentation of the global controlled release drug delivery market?
The controlled release drug delivery market covered in this report is segmented –
1) By Technology: Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Other Technologies
2) By Release Mechanism: Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-Modulated Drug Delivery Systems, Chemically Activated,
3) By Application: Metered Dose Inhalers, Injectable, Transdermal And Ocular Patches, Other Applications
4) By End User: Hospitals, Clinics, Personal, Research, Other End Users
Subsegments:
1) By Wurster Technique: Spray Coating, Fluid Bed Coating
2) By Coacervation: Simple Coacervation, Complex Coacervation
3) By Micro Encapsulation: Polymer-Based Micro Encapsulation, Lipid-Based Micro Encapsulation
4) By Implants: Biodegradable Implants, Non-Biodegradable Implants
5) By Transdermal: Microneedle Patches, Reservoir Systems, Matrix Systems
6) By Targeted Delivery: Nanoparticles, Antibody-Drug Conjugates, Liposomes
7) By Other Technologies: Osmotic Pumps, In Situ Gelling Systems
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9930&type=smp
Who are the dominant players expanding their reach in the controlled release drug delivery market?
Major companies operating in the controlled release drug delivery market include Johnson & Johnson Services Inc., Merck & Co. Inc., Alkermes plc, Coating Place Inc., Corium International Inc., Depomed Inc., Pfizer Inc., Aradigm Corporation, Capsugel LLC, GlaxoSmithKline plc, Bayer Healthcare LLC, Collegium Pharmaceuticals Inc., GE HealthCare Technologies Inc., Adare Pharmaceuticals Inc., Allergan plc, Novartis AG, Lonza Group AG, Colorcon Inc., SKY Pharmaceuticals Pvt. Ltd., AstraZeneca plc, Biogen Inc., Orbis Biosciences Inc., Alza Corporation, MicroCHIPS Inc., Endo International plc, Heron Therapeutics Inc., Intellipharmaceutics International Inc., Ipsen Biopharmaceuticals Inc., Luye Pharma Group Ltd., Medtronic plc, Nektar Therapeutics, Novo Nordisk A/S, Ocular Therapeutix Inc., Pacira BioSciences Inc., Progenity Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Titan Pharmaceuticals Inc., Vectura Group plc, West Pharmaceutical Services Inc., Zosano Pharma Corporation, Zynerba Pharmaceuticals Inc.
How are evolving market trends shaping controlled release drug delivery Strategies?
The controlled-release drug delivery market is increasingly embracing technological advancements as a key trend. To maintain their market positions, leading companies in this sector are adopting cutting-edge technologies. A case in point is Evonik Industries AG, a pharmaceutical company based in Germany, which introduced UDRATEC SoluFlow in March 2022. UDRATEC SoluFlow, a revolutionary microparticle technology, enhances the solubility of active ingredients in oral drugs. Unlike traditional production methods, this emulsion-based process technique is capable of overcoming solubility challenges. The addition of EUDRATEC SoluFlow has expanded Evonik Health Care’s collection of oral drug delivery solutions, which encompasses oral excipients like EUDRAGIT functional polymers, pre-filled functional capsules such as EUDRACAPTM, and a range of other techniques and services designed to enhance drug performance.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9930
Which regions are emerging as leaders in the controlled release drug delivery market?
North America was the largest region in the controlled release drug delivery market in 2024. The regions covered in the controlled release drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Drugs For Erectile Dysfunction Global Market Report 2024
Drugs For Hormonal Replacement Therapy Global Market Report 2024
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
